Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2017 (2017), Article ID 1237510, 4 pages
https://doi.org/10.1155/2017/1237510
Case Report

Jejunojejunal Intussusception due to Metastatic Melanoma Seven Years after the Primer

1Department of HPB Surgery, Royal London Hospital, London, UK
2Department of Surgery, European Interbalkan Medical Centre, Thessaloniki, Greece
3Department of Oncology, “Theagenion” Anti-Cancer Hospital, Thessaloniki, Greece
4Department of Anesthesiology, European Interbalkan Medical Centre, Thessaloniki, Greece
5Department of Pathology, European Interbalkan Medical Centre, Thessaloniki, Greece
6Division of Transplant Surgery, Department of Surgery, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Correspondence should be addressed to Dimitrios Giakoustidis

Received 6 June 2017; Accepted 13 August 2017; Published 12 September 2017

Academic Editor: Boris Kirshtein

Copyright © 2017 Alexander Giakoustidis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Intestinal intussusception in adults is a rare medical condition accounting for less than 5% of all intussusceptions. Herein we present a 45-year-old patient with a history of abdominal pain and loss of weight. CT scan revealed jejunojejunal intussusceptions. The patient was subjected to exploratory operation and small intestine resection due to a mass causing intestinal intussusception. Pathology confirmed suspected diagnosis of metastatic melanoma to small intestine secondary to melanoma, 7 years after the initial manifestation. Postoperative evaluation with 18FDG-PET/CT revealed increased uptake in the thyroid gland. Subsequent total thyroidectomy revealed severe Hashimoto thyroiditis and no signs of metastasis. The patient received adjuvant immunotherapy and is healthy with no signs of recurrence 3 years after the initial diagnosis and treatment.